Organon & (OGN) Prnewswire·2025-06-16 09:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to allegations of misleading statements and a significant reduction in quarterly dividends, which led to a sharp decline in stock price [1][2]. Group 1: Allegations and Impact - The class period for the allegations is from October 31, 2024, to April 30, 2025 [2]. - Defendants allegedly provided positive statements while concealing material adverse facts about Organon's capital allocation priorities, particularly regarding a debt reduction strategy after the acquisition of Dermavant [2]. - Following the announcement of a 70% decrease in the regular quarterly dividend, Organon's stock price plummeted from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, marking a decline of over 27% in one day [2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of July 22, 2025, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [4].